Langlai Technology
Wuhan
About Langlai Technology
Langlai Technology is a clinical-stage innovative drug research and development company. Adhering to the dual-drive strategy of synchronously improving the R&D pipeline and platform construction, it has built a full-process new drug R&D process from concept verification, candidate compound screening, preclinical druggability development to clinical research. system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $69.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: createrna.com
- Phone: 027-68788900
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/langlai-technology-40828 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.